Blueliner Group
San Diego is the second-largest biotech hub in the United States. Between the publicly traded majors, the acquirers, the growth-stage companies in S-1 preparation, and the broader life sciences and defense technology ecosystem, a meaningful number of senior employees and executives in this city hold equity compensation that will become a defining financial event in the next five years.
What follows is a practical reference to the vocabulary. Not advice on what to do with your specific grants — that work is done by your tax advisor and your registered investment advisor — but a framework for understanding the moving parts so the conversations with those professionals are productive when the window is short.
The instruments
Incentive Stock Options (ISOs). Employee stock options with favorable tax treatment if held correctly: no ordinary income tax at exercise, long-term capital gains treatment if shares are held more than one year from exercise and two years from grant. The trap is the alternative minimum tax (AMT). Exercising ISOs without selling the shares creates an AMT preference item equal to the bargain element — the spread between the strike price and the fair market value at exercise. In a year with a large ISO exercise, the AMT can be a significant cash bill even though no shares were sold.
Non-Qualified Stock Options (NSOs). Stock options without the favorable ISO tax treatment. The bargain element at exercise is taxed as ordinary income, withheld at exercise like wages. Future appreciation is taxed at capital gains rates. NSOs are common for executives, board members, advisors, and any employee whose ISOs exceed the $100,000 limit on the value of shares (measured at grant) that can first become exercisable in a single calendar year.
Restricted Stock Units (RSUs). A promise of shares at vest. Taxed as ordinary income at the value on the vest date, with shares typically delivered net of withholding. Public-company RSUs vest on a time-based schedule; private-company RSUs often have a double trigger requiring both time-based vesting and a liquidity event before shares are delivered.
Restricted Stock (with 83(b) opportunity). Shares granted subject to a vesting schedule, but you own the shares immediately. The 83(b) election, filed within 30 days of grant, lets you pay tax on the value at grant — typically very low for an early-stage company — rather than at each vest. Done correctly at a company that succeeds, the 83(b) election shifts enormous amounts of value from ordinary income to long-term capital gain. Missed, the opportunity is gone forever.
The events
Vesting cliffs and milestones. The first one-year cliff and each subsequent vesting milestone are decision points. They are not automatic events. ISO exercise timing in particular affects AMT exposure in the year of exercise and the holding-period clock for capital gains.
Pre-IPO windows. The months before an S-1 filing are the last window to consider early exercise of ISOs at a still-low strike price relative to fair market value. After the IPO, the bargain element grows quickly, and so does AMT exposure. For companies in San Diego biotech and defense technology, this window often closes on a timeline determined by the company, not the employee.
Lockup periods. Post-IPO lockups are typically 180 days. The day the lockup expires is a coordination problem as much as a financial one: if a meaningful percentage of insider holders are all selling the same week, the price action can be unkind. Lockup release strategy is investment advisor territory; planning the timeline around it is family office territory.
Acquisition announcements. When a San Diego biotech is acquired — a common pattern in the pipeline acquisitions of recent years, with Genentech, Pfizer, AbbVie, Merck, and Bristol Myers Squibb among the active acquirers — the tax consequences of cash versus stock consideration, acceleration provisions, and option treatment land within weeks. Pre-event modeling matters more than post-event optimization.
Tender offers and secondary sales. Growth-stage companies increasingly offer employees structured secondary opportunities before IPO. Each one is a tax event with specific considerations. The tax treatment depends on whether the shares are sold to the company (redemption) or to a third party.
The technical items that change outcomes by millions of dollars
Qualified Small Business Stock (QSBS). Section 1202 of the Internal Revenue Code can exclude up to $10 million — or 10 times basis, whichever is greater — of gain on qualifying stock held more than five years. Many San Diego biotech founders and early employees qualify and never realize it. Recent changes to the holding period rules under the One Big Beautiful Bill Act have expanded the framework. The qualification rules are technical: the company must have had gross assets under $50 million when the stock was issued, the company must be a C-corporation engaged in a qualified business (most biotech and life sciences qualify; certain services do not), and the five-year holding period clock matters. Worth a specific conversation with a tax advisor early.
Alternative Minimum Tax (AMT). The shadow tax system that determines whether an ISO exercise creates a tax bill in the year of exercise. AMT credit carries forward, which means a large AMT payment in one year can be partially recovered in future years against regular tax — but only if there is future regular tax to offset and the holder is alive to claim it. Multi-year AMT planning around an anticipated liquidity event is a coordination problem that touches the CPA, the registered investment advisor, and the employee’s personal cash flow.
Concentrated stock and diversification. A single equity position worth 70%, 80%, or 95% of a household’s liquid net worth is a concentration risk, not an investment thesis. Registered investment advisors use exchange funds, structured selling programs, and equity-based lending to address concentration without triggering an immediate avoidable tax bill. The framework that fits your situation depends on your tax position, your timeline, and your risk tolerance — and the work is done by the registered investment advisor delivering it.
Charitable structures. Donor-advised funds and charitable remainder trusts both have specific applications around a liquidity event. Donating appreciated stock before sale, in particular, can eliminate the capital gains tax on the donated portion while still providing a charitable deduction at fair market value. Timing matters: the donation must happen before the sale becomes contractually obligated.
The coordination problem
The single most consistent observation from working with people in this situation over the past two decades: the tax decision turns on an investment decision; the investment decision turns on the estate plan; the estate plan turns on the family situation; and no one professional sees more than one of those four. Each individual specialist is doing their job correctly. The cost shows up quietly in the seams.
The work of a coordinator — a personal CFO or a fractional family office, depending on the situation — is to make sure those conversations happen on time, with the right people in the room, with the right information in hand. The decisions themselves stay with the specialists: the tax advisor on tax, the registered investment advisor on investments, the estate attorney on estate documents. What changes is whether the decisions are made together or in isolation.
Worth reflecting on
If you are at a San Diego biotech or defense technology company with vested or unvested equity, a few questions worth carrying into the next conversation with your CPA and any advisors you work with:
- What is the AMT exposure in the year you are planning to exercise ISOs, and what is the plan to pay it?
- Do your shares qualify for QSBS treatment? If yes, where is the holding-period clock right now?
- If your company were acquired tomorrow at the consideration most likely to be offered, what would the tax bill be — and would you have the cash to pay it without forced selling?
- If your company filed its S-1 in the next six months, what would you wish you had done in the prior three years that you have not yet done?
The answers vary by situation. The questions are nearly universal.
Blueliner Group is not a registered investment advisor and does not provide personalized tax or investment advice. The above is educational reference. Specific recommendations about your equity compensation, tax position, or investment strategy are made by your tax advisor and your registered investment advisor, in coordination with your overall plan.